X

Vous n'êtes pas connecté

Maroc Maroc - ABUDHABIMAGAZINE.AE - A La Une - 12/Nov 16:03

New study finds Ozempic and Mounjaro protect the heart too

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss but also significantly reduce the risk of heart attacks and strokes in patients with type 2 diabetes. Using real-world insurance data, the study found up to an 18% reduction in major cardiovascular events, confirming powerful heart-protective effects that appear to extend beyond weight control.

Articles similaires

Sorry! Image not available at this time

Ozempic, Mounjaro cut stroke & heart attack risk in Diabetes

times of india - 15/Nov 20:53

New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study...

Sorry! Image not available at this time

Ozempic, Mounjaro cut stroke & heart attack risk in Diabetes

times of india - 15/Nov 20:53

New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study...

Sorry! Image not available at this time

All the News That’s Fit: Obesity drugs’ alcohol effect, cheaper insulin and turkey eating

wn.com - 25/Nov 14:05

For The Union-Tribune GLP one less for the road Apart from their widely celebrated effect at weight loss and diabetes management, GLP-1 drugs like...

Why popular weight-loss and diabetes drugs cause nausea easily

knowridge.com - 22/Nov 15:33

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only appetite but also the...

Why popular weight-loss and diabetes drugs cause nausea easily

knowridge.com - 22/Nov 15:33

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only appetite but also the...

Are popular diabetes and weight‑loss drugs equally safe?

knowridge.com - 21/Nov 00:47

Public interest in GLP‑1 receptor agonists has exploded in recent years. These medicines, known as GLP‑1 RAs, include drugs like semaglutide,...

Sorry! Image not available at this time

Quitting a GLP-1 Before Pregnancy Linked to Higher Weight Gain, Complications

drugs.com - 25/Nov 11:11

TUESDAY, Nov. 25, 2025 — Women who stop taking a GLP-1 weight loss/diabetes medication just prior to a pregnancy appear to be at higher odds for...

Diabetes and weight-loss drugs may boost colon cancer survival, study finds

knowridge.com - 16/Nov 11:00

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might also help people with colon...

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

the new york times - 24/Nov 22:18

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

the new york times - 24/Nov 22:18

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.